Drug × Cancer matrix

Drugs that target a gene either directly (oncogene) or via a synthetic-lethal partner (SLP) of a mutated tumour suppressor (TSG). Cell colour shows the strongest known status of that drug for that cancer subtype: approved clinical trial repositionable (potential reuse, no evidence yet) or blank.

Cancer key
GBM — Glioblastoma (CNS astrocytoma grade IV) LUAD — Lung adenocarcinoma SCLC — Small cell lung carcinoma LUSC — Lung squamous cell carcinoma OAC — Oesophageal adenocarcinoma OSCC — Oesophageal squamous cell carcinoma PDAC — Pancreatic ductal adenocarcinoma
Relationship
Show
Clear
Showing 200 of 894 drug-target rows in SSL view, for TSG = CREBBP.
Drug TSG SLP (drug target) GBM LUAD SCLC LUSC OAC OSCC PDAC #
docetaxel, thalidomide CREBBP BCL2 4
neo212 oral capsule, ipilimumab, pembrolizumab, nivolumab, regorafenib, carboplatin, paclitaxel, folfiri protocol, bevacizumab CREBBP ABL1 4
neo212 oral capsule, ipilimumab, pembrolizumab, nivolumab, regorafenib, carboplatin, paclitaxel, folfiri protocol, bevacizumab CREBBP BCL2 4
regorafenib, (stivarga, bay73-4506), nivolumab (opdivo) CREBBP ABL1 4
7-hydroxystaurosporine, irinotecan hydrochloride, diagnostic laboratory biomarker analysis CREBBP PDPK1 3
adavosertib, afatinib, afatinib dimaleate, binimetinib, biopsy, biospecimen collection, capivasertib, computed tomography, copanlisib, copanlisib hydrochloride, crizotinib, cytology specimen collection procedure, dabrafenib, dabrafenib mesylate, dasatinib, defactinib, defactinib hydrochloride, echocardiography, erdafitinib, fexagratinib, ipatasertib, laboratory biomarker analysis, larotrectinib, larotrectinib sulfate, magnetic resonance imaging, multigated acquisition scan, nivolumab, osimertinib, palbociclib, pertuzumab, pi3k-beta inhibitor gsk2636771, radiologic examination, radionuclide imaging, relatlimab, sapanisertib, sunitinib malate, taselisib, trametinib, trastuzumab, trastuzumab emtansine, ulixertinib, vismodegib CREBBP ABL1 3
adavosertib, afatinib, afatinib dimaleate, binimetinib, biopsy, biospecimen collection, capivasertib, computed tomography, copanlisib, copanlisib hydrochloride, crizotinib, cytology specimen collection procedure, dabrafenib, dabrafenib mesylate, dasatinib, defactinib, defactinib hydrochloride, echocardiography, erdafitinib, fexagratinib, ipatasertib, laboratory biomarker analysis, larotrectinib, larotrectinib sulfate, magnetic resonance imaging, multigated acquisition scan, nivolumab, osimertinib, palbociclib, pertuzumab, pi3k-beta inhibitor gsk2636771, radiologic examination, radionuclide imaging, relatlimab, sapanisertib, sunitinib malate, taselisib, trametinib, trastuzumab, trastuzumab emtansine, ulixertinib, vismodegib CREBBP EPHB4 3
adavosertib, afatinib, afatinib dimaleate, binimetinib, biopsy, biospecimen collection, capivasertib, computed tomography, copanlisib, copanlisib hydrochloride, crizotinib, cytology specimen collection procedure, dabrafenib, dabrafenib mesylate, dasatinib, defactinib, defactinib hydrochloride, echocardiography, erdafitinib, fexagratinib, ipatasertib, laboratory biomarker analysis, larotrectinib, larotrectinib sulfate, magnetic resonance imaging, multigated acquisition scan, nivolumab, osimertinib, palbociclib, pertuzumab, pi3k-beta inhibitor gsk2636771, radiologic examination, radionuclide imaging, relatlimab, sapanisertib, sunitinib malate, taselisib, trametinib, trastuzumab, trastuzumab emtansine, ulixertinib, vismodegib CREBBP PIK3CB 3
amg 193, docetaxel, comparator amg 193 test tablet CREBBP BCL2 3
bms-986340, bms-936558-01, docetaxel CREBBP BCL2 3
dec-205/ny-eso-1 fusion protein cdx-1401, laboratory biomarker analysis, pharmacological study, sirolimus CREBBP MTOR 3
everolimus CREBBP MTOR 7
regorafenib CREBBP ABL1 7
alectinib, brigatinib, lorlatinib 100 mg, osimertinib, sotorasib, dabrafenib, trametinib, selpercatinib, pembrolizumab, cemiplimab, nivolumab, carboplatin, pemetrexed, paclitaxel CREBBP ABL1 2
alectinib, brigatinib, lorlatinib 100 mg, osimertinib, sotorasib, dabrafenib, trametinib, selpercatinib, pembrolizumab, cemiplimab, nivolumab, carboplatin, pemetrexed, paclitaxel CREBBP BCL2 2
alendronate, etidronate, ibandronate, risedronate, raloxifene CREBBP ESR2 2
alvocidib, paclitaxel CREBBP BCL2 2
asp2138, pembrolizumab, oxaliplatin, leucovorin, fluorouracil, ramucirumab, paclitaxel, irinotecan CREBBP BCL2 2
bevacizumab, dasatinib, fluorouracil, leucovorin, leucovorin calcium, oxaliplatin, quality-of-life assessment CREBBP ABL1 2
bevacizumab, dasatinib, fluorouracil, leucovorin, leucovorin calcium, oxaliplatin, quality-of-life assessment CREBBP EPHB4 2
bryostatin 1, paclitaxel CREBBP BCL2 2
btla inhibitor (js004), toripalimab, paclitaxel, cisplatin CREBBP BCL2 2
capecitabine, docetaxel CREBBP BCL2 2
carboplatin, celecoxib, paclitaxel, adjuvant therapy, conventional surgery, neoadjuvant therapy CREBBP PDPK1 2
carboplatin, celecoxib, paclitaxel, adjuvant therapy, conventional surgery, neoadjuvant therapy CREBBP BCL2 2
carboplatin, docetaxel CREBBP BCL2 2
carboplatin, endoscopic biopsy, external beam radiation therapy, lenvatinib mesylate, paclitaxel, pembrolizumab, resection CREBBP BCL2 2
carboplatin, esophagectomy, intensity-modulated radiation therapy, paclitaxel, proton beam radiation therapy, quality-of-life assessment, questionnaire administration, folfox regimen, capox regimen, docetaxel, 5fu CREBBP BCL2 2
carboplatin, fluorouracil, paclitaxel, conventional surgery, radiation therapy CREBBP BCL2 2
carboplatin, paclitaxel, panitumumab, radiotherapy CREBBP BCL2 2
carboplatin, paclitaxel, radiation therapy, telomerase-specific type 5 adenovirus obp-301 CREBBP BCL2 2
carboplatin, paclitaxel, three-dimensional conformal radiation therapy CREBBP BCL2 2
cetuximab, cisplatin, docetaxel, adjuvant therapy, neoadjuvant therapy CREBBP BCL2 2
chemotherapy, cisplatin, paclitaxel, low-let electron therapy, low-let photon therapy CREBBP BCL2 2
cisplatin, docetaxel, irinotecan hydrochloride, radiation therapy CREBBP BCL2 2
cisplatin, fluorouracil, paclitaxel, conventional surgery, neoadjuvant therapy, radiation therapy CREBBP BCL2 2
cisplatin, fluorouracil, paclitaxel, surgical procedure, radiation therapy CREBBP BCL2 2
cisplatin, paclitaxel, surgical procedure, radiation therapy CREBBP BCL2 2
cixutumumab, everolimus, laboratory biomarker analysis, octreotide acetate, pharmacological study CREBBP MTOR 2
cixutumumab, laboratory biomarker analysis, paclitaxel, pharmacological study CREBBP BCL2 2
cpt- 11, cisplatin, celecoxib, radiation, surgery CREBBP PDPK1 2
dkn-01 150 mg, paclitaxel, pembrolizumab, dkn-01 300 mg CREBBP BCL2 2
docetaxel, 5-fu, radiotherapy, esophagectomy, dexamethasone CREBBP BCL2 2
durvalumab, tremelimumab, oxaliplatin, capecitabine, radiotherapy, paclitaxel, carboplatin, 5-fluorouracil (5-fu), leucovorin, docetaxel CREBBP BCL2 2
entrectinib, entrectinib, alectinib, atezolizumab, ipatasertib, trastuzumab emtansine, idasanutlin, inavolisib, belvarafenib, pralsetinib, gdc-6036, camonsertib CREBBP JAK2 2
filgrastim, cisplatin, fluorouracil, paclitaxel, radiation therapy CREBBP BCL2 2
filgrastim, paclitaxel, topotecan hydrochloride CREBBP BCL2 2
filgrastim, pegfilgrastim, cisplatin, fluorouracil, paclitaxel, conventional surgery, radiation therapy CREBBP BCL2 2
gemcitabine hydrochloride, paclitaxel, tipifarnib, radiation therapy CREBBP BCL2 2
ioa-244, avelumab injection, pemetrexed, cisplatin, ruxolitinib CREBBP JAK2 2
irinotecan, docetaxel CREBBP BCL2 2
melphalan, bcnu, vitamin b12b, vitamin c, ethanol, autologous hematopoietic stem cells CREBBP CHRNA9 2
melphalan, bcnu, vitamin b12b, vitamin c, ethanol, autologous hematopoietic stem cells CREBBP CACNG1 2
mk-0482, pembrolizumab, paclitaxel, nab-paclitaxel, gemcitabine, carboplatin, pemetrexed CREBBP BCL2 2
mk-4830, pembrolizumab, carboplatin, pemetrexed, lenvatinib, paclitaxel, cisplatin, mk-4830a CREBBP BCL2 2
ociperlimab, tislelizumab, pemetrexed, paclitaxel, nab paclitaxel, carboplatin, cisplatin, etoposide, 5fluorouracil, oxaliplatin, capecitabine CREBBP BCL2 2
olaparib CREBBP PARP3 2
onc-392, pembrolizumab, docetaxel CREBBP BCL2 2
paclitaxel CREBBP BCL2 2
pembrolizumab, paclitaxel CREBBP BCL2 2
pembrolizumab, paclitaxel, docetaxel, irinotecan CREBBP BCL2 2
pembrolizumab/vibostolimab co-formulation, pembrolizumab, lenvatinib, 5-fluorouracil, cisplatin, paclitaxel, gemcitabine, carboplatin, docetaxel, bevacizumab, capecitabine, oxaliplatin CREBBP BCL2 2
pralatrexate, docetaxel, fludeoxyglucose f 18, positron emission tomography CREBBP BCL2 2
ramucirumab, paclitaxel CREBBP BCL2 2
regorafenib, laboratory biomarker analysis CREBBP ABL1 2
temsirolimus CREBBP MTOR 2
temsirolimus, laboratory biomarker analysis CREBBP MTOR 2
bosutinib CREBBP ABL1 7
entrectinib CREBBP JAK2 7
ponatinib CREBBP ABL1 7
ruxolitinib CREBBP JAK2 7
tadalafil CREBBP PDE5A 7
18f-fluoromisonidazole, cediranib maleate, laboratory biomarker analysis, olaparib, positron emission tomography CREBBP PARP3 1
5-fluorouracil (5-fu), leucovorin, oxaliplatin, atezolizumab, cobimetinib, ramucirumab, paclitaxel, pegylated recombinant human hyaluronidase (pegph20), bl-8040, linagliptin, atezolizumab, cobimetinib, cisplatin, tiragolumab, 5-fluorouracil (5-fu) CREBBP BCL2 1
5-fluorouracil, docetaxel, oxaliplatin CREBBP BCL2 1
5-fluorouracil, leucovorin, oxaliplatin, docetaxel, carboplatin, paclitaxel, neoadjuvant radiation CREBBP BCL2 1
5-fluoruracil, cisplatinum, docetaxel CREBBP BCL2 1
5-fu, leucovorin, docetaxel, oxaliplatin (flot), trastuzumab, post-operative treatment trastuzumab mono therapy CREBBP BCL2 1
7-hydroxystaurosporine, fluorouracil CREBBP PDPK1 1
7-hydroxystaurosporine, gemcitabine hydrochloride, pharmacological study, laboratory biomarker analysis CREBBP PDPK1 1
aee788, everolimus CREBBP MTOR 1
afatinib, dasatinib, palbociclib, everolimus, olaparib CREBBP PARP3 1
afatinib, dasatinib, palbociclib, everolimus, olaparib CREBBP ABL1 1
afatinib, dasatinib, palbociclib, everolimus, olaparib CREBBP MTOR 1
afatinib, dasatinib, palbociclib, everolimus, olaparib CREBBP EPHB4 1
afatinib, docetaxel, radiation therapy CREBBP BCL2 1
afuresertib, nab paclitaxel, docetaxel, sintilimab CREBBP BCL2 1
agent-797, botensilimab, balstilimab, ramucirumab, paclitaxel CREBBP BCL2 1
ak109, paclitaxel, paclitaxel, ak104 CREBBP BCL2 1
aldesleukin, antibody therapy, fluorouracil, gemcitabine hydrochloride, irinotecan hydrochloride, laboratory biomarker analysis, leucovorin calcium, oxaliplatin, paclitaxel albumin-stabilized nanoparticle formulation, sargramostim CREBBP IL2RB 1
aldesleukin, autologous tumor cell vaccine, filgrastim, sargramostim, therapeutic autologous lymphocytes, carmustine, cisplatin, cyclophosphamide, paclitaxel, autologous bone marrow transplantation, conventional surgery, peripheral blood stem cell transplantation CREBBP IL2RB 1
aldesleukin, autologous tumor cell vaccine, filgrastim, sargramostim, therapeutic autologous lymphocytes, carmustine, cisplatin, cyclophosphamide, paclitaxel, autologous bone marrow transplantation, conventional surgery, peripheral blood stem cell transplantation CREBBP BCL2 1
aldesleukin, autologous tumor cell vaccine, muromonab-cd3, sargramostim, therapeutic autologous lymphocytes, surgical procedure, radiation therapy CREBBP IL2RB 1
aldesleukin, biopsy, biospecimen collection, computed tomography, cyclophosphamide, excisional biopsy, fludarabine, magnetic resonance imaging, standard treatment, therapeutic tumor infiltrating lymphocytes CREBBP IL2RB 1
aldesleukin, muromonab-cd3, therapeutic tumor infiltrating lymphocytes, conventional surgery CREBBP IL2RB 1
aldesleukin, therapeutic autologous lymphocytes, adjuvant therapy, conventional surgery CREBBP IL2RB 1
aldesleukin, therapeutic autologous lymphocytes, zoledronic acid CREBBP IL2RB 1
alpelisib, everolimus, exemestane CREBBP MTOR 1
alvocidib, docetaxel CREBBP BCL2 1
andecaliximab, gemcitabine, nab-paclitaxel, carboplatin, pemetrexed, leucovorin, oxaliplatin, 5-fu, bevacizumab, irinotecan, paclitaxel CREBBP BCL2 1
anetumab ravtansine, bevacizumab, paclitaxel CREBBP BCL2 1
apg101, alectinib, idasanutlin, atezolizumab, vismodegib, temsirolimus, palbociclib CREBBP MTOR 1
ascorbic acid, paclitaxel protein-bound, cisplatin, gemcitabine CREBBP EGLN1 1
atezolizumab, 5-fluorouracil, calciumfolinat, oxaliplatin, docetaxel CREBBP BCL2 1
atezolizumab, biospecimen collection, capecitabine, computed tomography, docetaxel, echocardiography, fluorouracil, leucovorin calcium, lymphadenectomy, magnetic resonance imaging, oxaliplatin, positron emission tomography, surgical procedure CREBBP BCL2 1
atezolizumab, tiragolumab, paclitaxel, cisplatin, atezolizumab matching placebo, tiragolumab matching placebo CREBBP BCL2 1
au-007, aldesleukin, avelumab CREBBP IL2RB 1
avelumab, irinotecan, paclitaxel, best supportive care (bsc) CREBBP BCL2 1
azacitidine, vorinostat, gemcitabine, busulfan, melphalan, dexamethasone, caphosol, glutamine, pyridoxine, rituximab CREBBP DNMT1 1
azd1775, olaparib CREBBP PARP3 1
azd6244, dacarbazine, erlotinib, docetaxel, temsirolimus CREBBP MTOR 1
azd6244, dacarbazine, erlotinib, docetaxel, temsirolimus CREBBP BCL2 1
bbi608, paclitaxel, placebo CREBBP BCL2 1
bemarituzumab, paclitaxel, ramucirumab, bemarituzumab, irinotecan, bemarituzumab, trifluridine/tipiracil CREBBP BCL2 1
bethanechol CREBBP CHRM5 1
bethanechol CREBBP CHRM4 1
bethanechol, gemcitabine, nab-paclitaxel CREBBP CHRM5 1
bethanechol, gemcitabine, nab-paclitaxel CREBBP CHRM4 1
bevacizumab, cediranib, cediranib maleate, olaparib CREBBP PARP3 1
bevacizumab, dasatinib, placebo CREBBP ABL1 1
bevacizumab, dasatinib, placebo CREBBP EPHB4 1
bevacizumab, docetaxel, oxaliplatin CREBBP BCL2 1
bevacizumab, everolimus, octreotide acetate CREBBP MTOR 1
bevacizumab, temsirolimus CREBBP MTOR 1
biological ni-1801, ni-1801 in combination with anti-pd1 (pembrolizumab), ni-1801 in combination with paclitaxel, paclitaxel CREBBP BCL2 1
biopsy, biospecimen collection, computed tomography, copanlisib, magnetic resonance imaging CREBBP PIK3CB 1
biopsy, biospecimen collection, computed tomography, magnetic resonance imaging, olaparib CREBBP PARP3 1
biopsy, biospecimen collection, computed tomography, magnetic resonance imaging, olaparib, pembrolizumab CREBBP PARP3 1
biopsy, biospecimen collection, copanlisib, radiologic examination CREBBP PIK3CB 1
biospecimen collection, computed tomography, endoscopic ultrasound, esophagogastroduodenoscopy, fluorouracil, hypofractionated radiation therapy, leucovorin calcium, oxaliplatin, positron emission tomography, survey administration, docetaxel CREBBP BCL2 1
biospecimen collection, computed tomography, magnetic resonance imaging, nivolumab, paclitaxel, questionnaire administration, ramucirumab CREBBP BCL2 1
biospecimen collection, computed tomography, magnetic resonance imaging, olaparib, placebo administration CREBBP PARP3 1
biospecimen collection, electronic health record review, fentanyl citrate, propofol, questionnaire administration, sevoflurane, surgical procedure CREBBP SCN4A 1
biospecimen collection, lidocaine, resection CREBBP SCN4A 1
bl-b01d1, irinotecan, paclitaxel, docetaxel CREBBP BCL2 1
bnt327 dose level 1 (dl1), bnt327 dose level 2 (dl2), etoposide, carboplatin, paclitaxel, topotecan CREBBP BCL2 1
bortezomib, carboplatin, paclitaxel CREBBP BCL2 1
botensilimab, balstilimab, chloroquine phosphate, celecoxib CREBBP PDPK1 1
cadonilimab, ak117, oxaliplatin, tegafur-gimeracil-oteracil potassium, docetaxel, 5-fluorouracil CREBBP BCL2 1
cadonilimab, pulocimab, paclitaxel, placebo CREBBP BCL2 1
cadonilimab, radiotherapy, carboplatin, paclitaxel CREBBP BCL2 1
camrelizumab, docetaxel, irinotecan CREBBP BCL2 1
camrelizumab, irinotecan, paclitaxel, paclitaxel-albumin, docetaxel, anlotinib CREBBP BCL2 1
camrelizumab, paclitaxel, cisplatin CREBBP BCL2 1
camrelizumab, paclitaxel, cisplatin, radiotherapy CREBBP BCL2 1
capecitabine, carboplatin, docetaxel, fluorouracil, hafnium oxide-containing nanoparticles nbtxr3, intensity-modulated radiation therapy, leucovorin, oxaliplatin, paclitaxel CREBBP BCL2 1
capecitabine, cisplatin, docetaxel, epirubicin hydrochloride, gemcitabine hydrochloride CREBBP BCL2 1
capecitabine, docetaxel, fluorouracil, leucovorin, oxaliplatin, radiation therapy, surgical procedure CREBBP BCL2 1
capecitabine, docetaxel, fluorouracil, oxaliplatin, radiation therapy, therapeutic conventional surgery CREBBP BCL2 1
capecitabine, medi4736 (durvalumab), trastuzumab, rucaparib, ramucirumab CREBBP PARP3 1
carboplatin, 3 dimensional conformal radiation therapy, propranolol, intensity modulated radiation therapy, paclitaxel CREBBP ADRB3 1
carboplatin, 3 dimensional conformal radiation therapy, propranolol, intensity modulated radiation therapy, paclitaxel CREBBP BCL2 1
carboplatin, cisplatin, docetaxel, etoposide, pembrolizumab CREBBP BCL2 1
carboplatin, computed tomography, fluorouracil, laboratory biomarker analysis, leucovorin calcium, oxaliplatin, paclitaxel, pembrolizumab, positron emission tomography, radiation therapy, therapeutic conventional surgery CREBBP BCL2 1
carboplatin, ganetespib, paclitaxel, radiation therapy CREBBP BCL2 1
carboplatin, laboratory biomarker analysis, paclitaxel, quality-of-life assessment, radiation therapy, therapeutic conventional surgery, trastuzumab CREBBP BCL2 1
carboplatin, laboratory biomarker analysis, paclitaxel, wild-type reovirus CREBBP BCL2 1
carboplatin, paclitaxel, azd1775 CREBBP BCL2 1
carboplatin, paclitaxel, vadimezan CREBBP BCL2 1
carboxyamidotriazole, paclitaxel CREBBP BCL2 1
catumaxomab, fluorouracil, leucovorin, oxaliplatin, docetaxel, fluorouracil, leucovorin, oxaliplatin, docetaxel CREBBP BCL2 1
ce-mark approved laa closure devices, acetylsalicylic acid, clopidogrel, dabigatran, rivaroxaban, apixaban, edoxaban, phenprocoumon, warfarin CREBBP TP53 1
celecoxib, cyclophosphamide, etoposide, thalidomide CREBBP PDPK1 1
celecoxib, isotretinoin, temozolomide, thalidomide CREBBP PDPK1 1
celecoxib, temozolomide, thalidomide, adjuvant therapy CREBBP PDPK1 1
ceralasertib, olaparib, durvalumab CREBBP PARP3 1
cetuximab (erbitux), paclitaxel, cisplatin, radiation CREBBP BCL2 1
cetuximab, cisplatin, paclitaxel, radiation therapy CREBBP BCL2 1
chemotherapy, cladribine, radiation therapy CREBBP PNP 1
chemotherapy, suramin CREBBP F2 1
chlorpromazine, temozolomide, radiation therapy CREBBP ADRA1A 1
cisplatin, docetaxel, floxuridine, fluorouracil, leucovorin calcium, conventional surgery CREBBP BCL2 1
cisplatin, docetaxel, fluorouracil, radiation therapy CREBBP BCL2 1
cisplatin, docetaxel, gemcitabine hydrochloride CREBBP BCL2 1
cisplatin, docetaxel, gemcitabine hydrochloride, irinotecan hydrochloride CREBBP BCL2 1
cisplatin, irinotecan hydrochloride, paclitaxel, conventional surgery, radiation therapy CREBBP BCL2 1
cisplatin, oxaliplatin, fluorouracil (5-fu), capecitabine, paclitaxel, tislelizumab, placebo CREBBP BCL2 1
cisplatin, paclitaxel, 5-fu CREBBP BCL2 1
cisplatin, paclitaxel, adjuvant therapy, radiation therapy CREBBP BCL2 1
cisplatin, paclitaxel, brachytherapy, radiation therapy CREBBP BCL2 1
cisplatin, paclitaxel, surgical procedure CREBBP BCL2 1
cisplatin, paclitaxel, topotecan hydrochloride CREBBP BCL2 1
cobimetinib, olaparib, onvansertib, azenosertib, saruparib, tremelimumab CREBBP PARP3 1
conventional surgery, laboratory biomarker analysis, sorafenib tosylate, temsirolimus CREBBP MTOR 1
crenolanib, ramucirumab, paclitaxel CREBBP BCL2 1
cyclophosphamide, fludarabine, aldesleukin, anti-hcd70 car transduced pbl CREBBP IL2RB 1
cytoreductive surgery, perifosine, temsirolimus CREBBP MTOR 1
dabigatran etexilate, warfarin CREBBP F2 1
dalteparin, gemcitabine hydrochloride, diagnostic laboratory biomarker analysis CREBBP SERPINC1 1
dalteparin, gemcitabine hydrochloride, diagnostic laboratory biomarker analysis CREBBP SELP 1
dalteparin, radiation therapy CREBBP SERPINC1 1
dalteparin, radiation therapy CREBBP SELP 1
dasatinib, erlotinib hydrochloride, gemcitabine hydrochloride CREBBP ABL1 1
dasatinib, erlotinib hydrochloride, gemcitabine hydrochloride CREBBP EPHB4 1
dasatinib, gemcitabine hydrochloride, laboratory biomarker analysis, mutation analysis, nucleic acid sequencing, immunohistochemistry staining method CREBBP ABL1 1
dasatinib, gemcitabine hydrochloride, laboratory biomarker analysis, mutation analysis, nucleic acid sequencing, immunohistochemistry staining method CREBBP EPHB4 1
dasatinib, laboratory biomarker analysis, physiologic testing CREBBP ABL1 1
dasatinib, laboratory biomarker analysis, physiologic testing CREBBP EPHB4 1
dasatinib, mfolfox6 CREBBP ABL1 1
dasatinib, mfolfox6 CREBBP EPHB4 1
Approval data manually curated from National Cancer Institute and Drugs@FDA. Clinical trials from ClinicalTrials.gov. Repositionable candidates from cansar.ai — these are potential drug-cancer reuse candidates, not evidence of efficacy.